SCHEMBL5316740

SCHEMBL5316740

Cc1nc(-c2nn(-c3csc(C)n3)cc2NC(=O)c2c(F)cccc2F)cs1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
KDM4E B2RXH2 1/20 0.47
PKM P14618 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MAPT P10636 3/20 0.43
TP53 P04637 1/20 0.43
MEN1 O00255 6/20 0.40
KMT2A Q03164 6/20 0.40
ABL1 P00519 1/20 0.39
GAA P10253 1/20 0.39
BLM P54132 1/20 0.38
MAPK1 P28482 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ALDH1A1 P00352 2/20 0.37
HPGD P15428 1/20 0.37
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3584925 0.77 NPC1 (0.51) NPC1RAB9AKDM4EPKMSMN1; SMN2
SCHEMBL5370461 0.70 MEN1 (0.38) KDM4EMAPTTP53MEN1KMT2A
SCHEMBL5530009 0.70 GAA (0.60) NPC1RAB9AKDM4EPKMSMN1; SMN2
SCHEMBL15702691 0.68 MEN1 (0.55) NPC1RAB9AKDM4EPKMSMN1; SMN2
SCHEMBL5051473 0.66 KMT2A (0.53) NPC1RAB9AKDM4EPKMSMN1; SMN2
SCHEMBL16403955 0.62 NPC1 (0.51) NPC1RAB9AKDM4EPKMSMN1; SMN2
SCHEMBL3578005 0.62 SMN1; SMN2 (0.50) NPC1RAB9AKDM4ESMN1; SMN2MAPT
SCHEMBL1243071 0.62 SMN1; SMN2 (0.69) NPC1RAB9ASMN1; SMN2MAPTGAA
SCHEMBL9079544 0.62 MEN1 (0.48) NPC1KDM4ESMN1; SMN2MAPTTP53
SCHEMBL14887518 0.61 ATR (0.45) KDM4EMAPTMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836188-A1 PYRAZOLE DERIVATIVES AS THAT MODULATE THE ACTIVITY OF CDK, GSK AND AURORA KINASES Astex Therapeutics Limited (GB) 2007-09-26 EP disclosed
WO-2006070198-A1 PYRAZOLE DERIVATIVES AS THAT MODULATE THE ACTIVITY OF CDK, GSK AND AURORA KINASES ASTEX THERAPEUTICS LIMITED (GB) 2006-07-06 WO disclosed